Illumina pushes back against Carl Icahn's proxy fight over Grail deal

Illumina pushed back against Carl Icahn's proxy fight over the Grail deal, saying it's committed to maximizing shareholder value as it works ...

Investor Carl Icahn waging another proxy battle over Illumina's failed ...

Icahn filed a letter expressing his intent to oust Illumina board members who oversaw the Grail deal. ... The company has pushed back on ...

Illumina facing Icahn-led proxy battle over Grail buy: WSJ

Illumina facing proxy battle led by activist investor Carl Icahn over Grail ... to after attempts to strike a deal with Illumina came up short. “ ...

Illumina pushes back against activist investor Carl Icahn's bid for ...

... diagnostic outfit Grail Inc. for $7.1 billion.News of Icahn's proxy fight sent Illumina's shares surging nearly 17 percent to $226.94 on the […]

Illumina-Icahn proxy battle heats up as Grail divestment orders loom

The DNA-sequencing provider is headed for a showdown with billionaire financier Carl Icahn over three seats on its board as it continues to ...

Inside Illumina's brutal proxy fight with Carl Icahn | Fortune

Today, Illumina is still waiting for a ruling from an EU court over whether the EU Commission has jurisdiction to block its Grail deal. As ...

Carl Icahn's Proxy Fight With Illumina Comes to a Vote

Shareholders are set to vote on Thursday whether to back the gene-sequencing company's incumbent board or candidates named by the activist ...

Illumina nearly settled with Icahn before proxy fight broke out - Axios

Illumina nearly avoided its fight with Carl Icahn via an agreement that would have put one nominee of the veteran activist on the company's ...

Biotech company Illumina pushes back against Carl Icahn's proxy ...

Illumina pushed back against Carl Icahn's proxy fight over the Grail deal, saying it's committed to maximizing shareholder value as it works with ...

Biotech company Illumina pushes back against Carl Icahn's proxy ...

Biotech company Illumina pushes back against Carl Icahn's proxy fight over $7.1 billion Grail deal. Avatar photo. by CNBC 2023-03-20. See all articles. Biotech ...

Carl Icahn sues Illumina and its board over Grail deal fallout

Carl Icahn's proxy battle against Illumina led to the replacement of its chairman and the resignation of its CEO. Now, the activist investor ...

Icahn urges Illumina to unwind Grail deal, pushes ahead on proxy fight

In his second letter to Illumina shareholders this week, Icahn wrote the "only path forward is for Grail to be divested".

Illumina names new CEO months after Icahn proxy fight over Grail deal

The announcement comes after a proxy fight with activist investor Carl Icahn, which ended with Illumina's former CEO Francis deSouza ...

Illumina Pushes Back Against Icahn's Proposed Board Nominees ...

The company issued a defense of its management and board while striking back against Carl Icahn's recent comments and moves to start a proxy fight for the ...

Icahn, Illumina privately discussed settlement before public fight - filing

Activist investor Carl Icahn and Illumina Inc had weeks-long private negotiations before he started a proxy fight to push the U.S. life ...

Biotech company Illumina pushes back against Carl Icahn's proxy ...

Illumina pushed back against Carl Icahn's proxy fight over the Grail deal, saying it's committed to maximizing shareholder value as it works with regulators.

Icahn, Illumina discussed settlement before proxy fight – filing

March 30 (Reuters) – Activist investor Carl Icahn and U.S. life sciences firm Illumina failed to reach a settlement during weeks-long ...

Illumina's Francis deSouza touts Grail acquisition amid Carl Icahn ...

Illumina's Francis deSouza touts Grail acquisition amid Carl Icahn proxy fight. Illumina CEO Francis deSouza discusses how the biotech ...

Icahn pushes for spinoff of Illumina's Grail liquid biopsy unit

Activist shareholder Carl Icahn, in the midst of a proxy battle with Illumina ... return to a focus on its core DNA-sequencing business. In ...

Illumina chair ousted in proxy battle with Carl Icahn - Financial Times

Vote to remove John Thompson is the culmination of one of the largest shareholder activism campaigns in years.